🔎 Trials Near Me

Home › Major Depressive Disorder › Ohio › Cincinnati

Pag-aaral pangklinika para sa Major Depressive Disorder sa Cincinnati, OH

Isang pag-aaral para sa Major Depressive Disorder ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Cincinnati. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Nagre-recruitPhase 3
  • Patient Priority Clinical Sites LLC, Cincinnati
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06559306

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

Nagre-recruitPhase 3
  • University of Cincinnati, Cincinnati
Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07227454

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Nagre-recruitPhase 3
  • University of Cincinnati Medical Center, Cincinnati
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT05850689

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

Nagre-recruitPhase 3
  • Patient Priority Clinical Sites LLC, Cincinnati
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07573176

Study of ALTO-300 in MDD

Nagre-recruitPhase 2
  • Site 202, Cincinnati
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT05922878

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Nagre-recruitPhase 3
  • Clinical Research Site, Cincinnati
  • Clinical Research Site, Cincinnati
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT07484217

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

Nagre-recruitPhase 3
  • Vanda Investigational Site, Cincinnati
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06830044

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Nagre-recruitPhase 3
  • Neurocrine Clinical Site, Mason · 19 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT06911112

Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains

Nagre-recruitPhase 1/2
  • Lindner Center of Hope, Mason · 19 mi ang layo
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06795451

Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation

Nagre-recruit
  • Cincinnati Childrens Hospital Medical Center, Cincinnati
Edad 14 hanggang 18 · Lahat ng kasarian · Na-update Peb 11, 2026 · NCT07217444

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Nagre-recruitPhase 4
  • Clinical Research Site, Cincinnati
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ene 23, 2025 · NCT06223880

Pag-aaral para sa Major Depressive Disorder sa ibang lungsod

Iba pang pag-aaral sa Cincinnati

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.